Plk1-dependent microtubule dynamics promotes androgen receptor signaling in prostate cancer

Recent Advances in the Development of P-gp Inhibitors

(2012) Christiane Baumert et al.   Anti-Cancer Agents in Medicinal Chemistry

Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer

(2011) M. S. Darshan et al.   CANCER RESEARCH

Polo-like Kinase 1 Facilitates Loss of Pten Tumor Suppressor-induced Prostate Cancer Formation

(2011) X. Shawn Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Castration-refractory prostate cancer: New drugs in the pipeline

(2010) Dirk Schrijvers et al.   ADVANCES IN THERAPY

Phosphorylation of CLIP-170 by Plk1 and CK2 promotes timely formation of kinetochore–microtubule attachments

(2010) Hongchang Li et al.   EMBO JOURNAL

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

(2010) Klaus Strebhardt   NATURE REVIEWS DRUG DISCOVERY

Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase

(2010) H. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The substrates of Plk1, beyond the functions in mitosis

(2010) X. Shawn Liu et al.   Protein & Cell

Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer

(2009) L. Gan et al.   CANCER RESEARCH

Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trends

(2009) Alvaro Moreno-Aspitia et al.   CLINICAL THERAPEUTICS

Cdc2-mediated Phosphorylation of CLIP-170 Is Essential for Its Inhibition of Centrosome Reduplication

(2009) Xiaoming Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Actin filament dynamics are dominated by rapid growth and severing activity in theArabidopsiscortical array

(2009) Christopher J. Staiger et al.   JOURNAL OF CELL BIOLOGY